Logo image of BIRD

ALLBIRDS INC-CL A (BIRD) Stock Fundamental Analysis

NASDAQ:BIRD - Nasdaq - US01675A2087 - Common Stock - Currency: USD

6.98  -0.1 (-1.41%)

Fundamental Rating

3

Taking everything into account, BIRD scores 3 out of 10 in our fundamental rating. BIRD was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. BIRD has a great financial health rating, but its profitability evaluates not so good. BIRD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BIRD has reported negative net income.
In the past year BIRD has reported a negative cash flow from operations.
BIRD had negative earnings in each of the past 5 years.
In the past 5 years BIRD always reported negative operating cash flow.
BIRD Yearly Net Income VS EBIT VS OCF VS FCFBIRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

The Return On Assets of BIRD (-49.41%) is worse than 93.75% of its industry peers.
Looking at the Return On Equity, with a value of -91.77%, BIRD is doing worse than 85.42% of the companies in the same industry.
Industry RankSector Rank
ROA -49.41%
ROE -91.77%
ROIC N/A
ROA(3y)-40.03%
ROA(5y)-28%
ROE(3y)-68.68%
ROE(5y)-46.4%
ROIC(3y)N/A
ROIC(5y)N/A
BIRD Yearly ROA, ROE, ROICBIRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

The Gross Margin of BIRD (42.72%) is worse than 66.67% of its industry peers.
BIRD's Gross Margin has declined in the last couple of years.
BIRD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.86%
GM growth 5Y-3.48%
BIRD Yearly Profit, Operating, Gross MarginsBIRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

7

2. Health

2.1 Basic Checks

BIRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
BIRD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BIRD has been reduced compared to 5 years ago.
There is no outstanding debt for BIRD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BIRD Yearly Shares OutstandingBIRD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
BIRD Yearly Total Debt VS Total AssetsBIRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

BIRD has an Altman-Z score of -3.29. This is a bad value and indicates that BIRD is not financially healthy and even has some risk of bankruptcy.
BIRD has a worse Altman-Z score (-3.29) than 87.50% of its industry peers.
BIRD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.29
ROIC/WACCN/A
WACC10.25%
BIRD Yearly LT Debt VS Equity VS FCFBIRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.94 indicates that BIRD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.94, BIRD belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
BIRD has a Quick Ratio of 1.95. This is a normal value and indicates that BIRD is financially healthy and should not expect problems in meeting its short term obligations.
BIRD's Quick ratio of 1.95 is amongst the best of the industry. BIRD outperforms 89.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 1.95
BIRD Yearly Current Assets VS Current LiabilitesBIRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.25% over the past year.
Looking at the last year, BIRD shows a very negative growth in Revenue. The Revenue has decreased by -25.31% in the last year.
BIRD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.41% yearly.
EPS 1Y (TTM)22.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.71%
Revenue 1Y (TTM)-25.31%
Revenue growth 3Y-11.9%
Revenue growth 5Y-0.41%
Sales Q2Q%-18.34%

3.2 Future

BIRD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.25% yearly.
BIRD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.04% yearly.
EPS Next Y15.07%
EPS Next 2Y14.17%
EPS Next 3Y18.25%
EPS Next 5YN/A
Revenue Next Year-7.21%
Revenue Next 2Y-1.28%
Revenue Next 3Y1.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BIRD Yearly Revenue VS EstimatesBIRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 100M 200M 300M 400M 500M
BIRD Yearly EPS VS EstimatesBIRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BIRD. In the last year negative earnings were reported.
Also next year BIRD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BIRD Price Earnings VS Forward Price EarningsBIRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIRD Per share dataBIRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as BIRD's earnings are expected to grow with 18.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.17%
EPS Next 3Y18.25%

More info and screens

0

5. Dividend

5.1 Amount

BIRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALLBIRDS INC-CL A

NASDAQ:BIRD (5/30/2025, 11:42:07 AM)

6.98

-0.1 (-1.41%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)N/A N/A
Inst Owners39.2%
Inst Owner Change-0.87%
Ins Owners1.01%
Ins Owner Change0.93%
Market Cap56.26M
Analysts74.55
Price Target10.2 (46.13%)
Short Float %16.48%
Short Ratio16.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.53%
Min EPS beat(2)7.68%
Max EPS beat(2)17.38%
EPS beat(4)4
Avg EPS beat(4)20.23%
Min EPS beat(4)7.68%
Max EPS beat(4)32.77%
EPS beat(8)8
Avg EPS beat(8)19.75%
EPS beat(12)11
Avg EPS beat(12)14.98%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.2%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)1.58%
Revenue beat(4)2
Avg Revenue beat(4)-0.74%
Min Revenue beat(4)-2.66%
Max Revenue beat(4)1.58%
Revenue beat(8)5
Avg Revenue beat(8)1.03%
Revenue beat(12)6
Avg Revenue beat(12)-0.3%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25%
PT rev (3m)11.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.44%
EPS NY rev (1m)6.61%
EPS NY rev (3m)9.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14%
Revenue NY rev (1m)-0.6%
Revenue NY rev (3m)-3.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)-11.04
EYN/A
EPS(NY)-8.16
Fwd EYN/A
FCF(TTM)-8.43
FCFYN/A
OCF(TTM)-7.92
OCFYN/A
SpS23.54
BVpS12.62
TBVpS12.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49.41%
ROE -91.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.72%
FCFM N/A
ROA(3y)-40.03%
ROA(5y)-28%
ROE(3y)-68.68%
ROE(5y)-46.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.86%
GM growth 5Y-3.48%
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.03%
Cap/Sales 2.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.94
Quick Ratio 1.95
Altman-Z -3.29
F-Score4
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)99.47%
Cap/Depr(5y)150.28%
Cap/Sales(3y)5.66%
Cap/Sales(5y)6.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.71%
EPS Next Y15.07%
EPS Next 2Y14.17%
EPS Next 3Y18.25%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.31%
Revenue growth 3Y-11.9%
Revenue growth 5Y-0.41%
Sales Q2Q%-18.34%
Revenue Next Year-7.21%
Revenue Next 2Y-1.28%
Revenue Next 3Y1.04%
Revenue Next 5YN/A
EBIT growth 1Y20.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.49%
EBIT Next 3Y22.17%
EBIT Next 5YN/A
FCF growth 1Y-65.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-111.3%
OCF growth 3YN/A
OCF growth 5YN/A